- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06718777
Effect of Two Different Solutions on Wound Healing in Pressure Injury
December 4, 2024 updated by: Mensure Turan
Effect of Two Different Solutions Used in Pressure Injury Care on Wound Healing Process
Pressure injuries are a condition that reduces patients' quality of life, increases hospitalization time and healthcare costs.
When accompanied by infection and complications, mortality increases.
The primary goal in pressure injuries is to prevent their occurrence, but once the injury has occurred, it is to provide effective and appropriate care.
It is known that 0.9% sodium chloride (NaCl) is used routinely in pressure ulcer care.
In addition, if the effectiveness of 0.1% polyhexanide in pressure ulcer care is demonstrated, it may provide data for its use in wound care.
For this purpose, the study was completed as a randomized controlled trial with 32 individuals in the 0.1% polyhexanide group and 31 individuals in the 0.9% NaCl group, totaling 63 individuals.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The European Pressure Ulcer Advisory Panel (EPUAP) and the National Pressure Ulcer Advisory Panel (NPUAP) defined pressure injury (PI) as "Local skin and/or subcutaneous tissue damage caused by pressure alone, or by a combination of pressure and shear, most often occurring over bony prominences".
It has been stated that the prevalence of pressure ulcers varies between 0-72.5%, and that it is a condition that reduces the quality of life of patients, increases the length of hospital stay and health care costs.
In particular, the accompanying infection and complications of PI cause increased mortality.
The primary purpose of PIs is to prevent their occurrence and after the injury occurs, it is necessary to provide care with effective and appropriate methods.
The determined method should have the feature that can contribute to wound healing.
There are many products and methods with appropriate features that can be used in PIs.
In addition to the wet-dry gauze dressing used in wound care from past to present, different care solutions are also used.
0.9% NaCl solutions are frequently used in wound care.
Since 0.1% polyhexanide solution is also an effective antiseptic, we thought that its use in PI care would contribute to treatment management by determining its effect on wound healing.
Study Type
Interventional
Enrollment (Actual)
63
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Diyarbakır, Turkey, 21000
- Gazi Yaşargil Training and Research Hospital
-
Diyarbakır, Turkey
- Gazi Yaşargil Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients over the age of 18 who have developed pressure injuries
- Patients who have received informed consent from themselves or their guardians
Exclusion Criteria:
- Patients with clotting problems
- Patients using corticosteroids
- Patients receiving additional medical treatment for wound care
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 0.1% polyhexanide
0.1% polyhexanide solution was applied 3 times at 48-hour intervals for pressure ulcer care.
|
After the patient was randomized for pressure ulcer care, data were recorded at the first follow-up before care and pressure ulcer care was performed with 0.1% polyhexanide solution.
Then, 2 treatments were performed at 48-hour intervals and PUSH scores were recorded before each care.
A total of three pressure ulcer care and four follow-ups were performed.
|
|
Experimental: 0.9% NaCl
0.9% sodium chloride solution was applied three times at 48-hour intervals for pressure ulcer care.
|
After the patient was randomized for pressure ulcer care, data were recorded at the first follow-up before care and pressure ulcer care was performed with 0.9% sodium chloride.
Then, 2 care sessions were performed at 48-hour intervals and PUSH scores were recorded before each care.
A total of three pressure ulcer care sessions and four follow-ups were performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PUSH score
Time Frame: From 0th hour to 144th hour
|
This scale, developed by NPUAP to evaluate the healing process of pressure injuries, was used in the study to evaluate the healing status of pressure injuries in patients receiving pressure injury care.
The pressure injury healing status was monitored with the evaluation criteria in the scale.
The lowest score to be received from PUSH is 0, and the highest score is 17.
A decrease in the score indicates that the pressure injury has healed.
|
From 0th hour to 144th hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
NPUAP Pressure Sore Classification System
Time Frame: 0th hour
|
Staging of pressure ulcers is important to assess the stage of the wound after it has formed to determine effective treatment methods.
Staging indicates the severity of the pressure ulcer, its depth, the extent of skin affected, and the extent of tissue damage.
The latest update was published by the NPUAP and EPUAP in 2009 as six stages.
|
0th hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mensure Turan, PhD, Şırnak Üniversitesi
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2023
Primary Completion (Actual)
January 1, 2024
Study Completion (Actual)
August 1, 2024
Study Registration Dates
First Submitted
November 4, 2024
First Submitted That Met QC Criteria
December 4, 2024
First Posted (Estimated)
December 5, 2024
Study Record Updates
Last Update Posted (Estimated)
December 5, 2024
Last Update Submitted That Met QC Criteria
December 4, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023/39
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.